title: The influence of a combined oral contraceptive on uterine activity and reactivity to agonists in primary dysmenorrhea.
abstract: The mechanisms underlying the therapeutic effect of an oral contraceptive (150 micrograms levonorgestrel and 30 micrograms ethinyl estradiol daily for 21 days) in primary dysmenorrhea were studied by recordings of uterine activity and reactivity to lysine (L) vasopressin (VP) and prostaglandin (PG) F2 alpha on the first day of menstruation in 14 women before and after one period of oral contraceptive treatment. During the first session, when all women had moderate to severe dysmenorrhea, intra-uterine pressure recording showed an intensive uterine activity, and bolus injections of LVP (6 pmol/kg body weight; 6 subjects) or PGF2 alpha (6 or 12 nmol/kg body weight; 4 subjects in each group) increased contractile activity and discomfort. After oral contraceptive treatment, spontaneous uterine activity, measured as total pressure area, decreased significantly (p = 0.02 and p = 0.03 in the VP and PG groups, respectively). The mean uterine responses to LVP and PGF2 alpha were on average smaller after oral contraceptive treatment and the women experienced minimal discomfort after this injection. It is suggested that inhibition of uterine activity could be an important mechanism for the therapeutic effect of gestagen-dominated oral contraceptives in primary dysmenorrhea and that reduced uterine reactivity to agonists might contribute to this effect.
authors: Department of Obstetrics and Gynecology, University Hospitals of Lund, Sweden.
authors: A
authors: A
authors: Hauksson
authors: P
authors: P
authors: Ekström
authors: E
authors: E
authors: Juchnicka
authors: T
authors: T
authors: Laudański
authors: M
authors: M
authors: Akerlund
mesh_terms: D000293:Adolescent; D000328:Adult; D003277:Contraceptives, Oral, Combined / Q000627:therapeutic use*; D015237:Dinoprost / Q000008:administration & dosage; D004412:Dysmenorrhea / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008236:Lypressin / Q000008:administration & dosage; D011312:Pressure; D014590:Uterine Contraction / Q000187:drug effects*; D014599:Uterus / Q000187:drug effects / Q000503:physiopathology
chemical_list: D003277:Contraceptives, Oral, Combined; D008236:Lypressin; D015237:Dinoprost